Background and purpose: The accuracy of dose calculation and delivery of a
commercial serial tomotherapy treatment planning and delivery system (Peaco
ck, NOMOS Corporation) was experimentally determined.
Materials and methods: External beam fluence distributions were optimized a
nd delivered to test treatment plan target volumes, including three with cy
lindrical targets with diameters ranging from 2.0 to 6.2 cm and lengths of
0.9 through 4.8 cm, one using three cylindrical targets and two using C-sha
ped targets surrounding a critical structure, each with different dose dist
ribution optimization criteria. Computer overlays of film-measured and calc
ulated planar dose distributions were used to assess the dose calculation a
nd delivery spatial accuracy. A 0.125 cm(3) ionization chamber was used to
conduct absolute point dosimetry verification. Thermoluminescent dosimetry
chips, a small-volume ionization chamber and radiochromic film were used as
independent checks of the ion chamber measurements.
Results: Spatial localization accuracy was found to be better than +/-2.0 m
m in the transverse axes (with one exception of 3.0 mm) and +/-1.5 mm in th
e longitudinal axis. Dosimetric verification using single slice delivery ve
rsions of the plans showed that the relative dose distribution was accurate
to +/-2% within and outside the target volumes (in high dose and low dose
gradient regions) with a mean and standard deviation for all points of -0.0
5% and 1.1%, respectively. The absolute dose per monitor unit was found to
vary by +/-3.5% of the mean value due to the lack of consideration for leak
age radiation and the limited scattered radiation integration in the dose c
alculation algorithm. To deliver the prescribed dose, adjustment of the mon
itor units by the measured ratio would be required.
Conclusions: The treatment planning and delivery system offered suitably ac
curate spatial registration and dose delivery of serial tomotherapy generat
ed dose distributions. The quantitative dose comparisons were made as far a
s possible from abutment regions and examination of the dosimetry of these
regions will also be important. Because of the variability in the dose per
monitor unit and the complex nature of the calculation and delivery of seri
al tomotherapy, patient-specific quality assurance procedures will include
a measurement of the delivered target dose. (C) 1999 Elsevier Science Irela
nd Ltd. All rights reserved.